•  Mesirow deepens its healthcare sector capabilities and coverage by hiring seasoned industry veteran John Calcagnini
• Expertise spans mergers and acquisitions, joint ventures, restructurings, leveraged buyouts, recapitalizations, and financing transactions 

CHICAGO, February 18, 2025 –Mesirow, an independent, employee-owned financial services firm, today announced the addition of John Calcagnini as a Managing Director in its Investment Banking group. Based in Los Angeles, John will expand Mesirow’s healthcare coverage by leveraging his extensive industry knowledge and deep transactional expertise across medical devices, diagnostics, and healthcare services. John will partner with Lance Bell, and together they will co-lead Mesirow’s healthcare sector coverage. 

Rocky Pontikes, Co-Head of Mesirow Investment Banking said, “Healthcare continues to be a dynamic and rapidly evolving sector, and hiring someone of John’s caliber underscores Mesirow’s commitment to enhancing our sector-focused strategy by partnering with seasoned investment bankers to provide successful outcomes for our clients.”

John brings more than 25 years of investment banking experience, having executed many notable healthcare transactions spanning mergers, acquisitions, joint ventures, leveraged buyouts, restructurings, and capital raises. Prior to joining Mesirow, John was a Managing Director in the healthcare practice of Stout’s Investment Banking group. He has also held leadership roles as Head of Healthcare at CRT Capital Group and Head of Medical Device Investment Banking at CIBC World Markets/Oppenheimer.

“Joining Mesirow represents an incredible opportunity to contribute to a firm with a strong culture and a reputation for excellence in investment banking,” said John Calcagnini. “I look forward to leveraging Mesirow’s integrated platform and collaborating with the team to provide my advice, leadership and experience that meet the unique needs of our healthcare clients.”

Recognized as a leader in the field, John has been honored three times by The Wall Street Journal as an All-Star Equity Research Analyst and was named one of the Most Influential Investment Bankers by the Los Angeles Business Journal in 2019.

“We are pleased to welcome John to the team,” added Adam Oakley, Co-Head of Mesirow Investment Banking. “John’s proven track record in the healthcare sector, combined with his dedication to delivering tailored solutions for clients, will significantly enhance our capabilities and presence in this large and growing end-market.”

Mesirow Investment Banking has completed more than 325 transactions in recent years across its ten covered industry verticals. With a focus on middle-market M&A, its clients include entrepreneurs, financial sponsors, and large corporations. Committed to leveraging extensive sector-specific expertise and nurturing deep longstanding relationships, Mesirow has a proven track record of completing highly tailored and successful transactions.